To further determine the impact of hepatic TET1 on MASLD progression, we generated a novel mouse strain of TET1 LKO by breeding the floxed TET1 mice with albumin promoter driven Cre ones. Here, ALB is linked to metabolic dysfunction-associated steatotic liver disease.